News and Trends 30 Jan 2018Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid… January 30, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 6 Apr 2017How is Biotech Transforming Pharma’s R&D Model? Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances and acquisitions play in this… April 6, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Jan 2017The Shiniest Golden Vertex? 15 Great Biotechs in Cambridge Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an exciting entrepreneurial scene at the… January 30, 2017 - 8 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jan 2017An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics The MultipleMS Consortium has been granted €15M by the EU Horizon 2020 to improve the treatment of multiple sclerosis using personalized… January 2, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 20167 European Institutions in the Largest Cancer Bioinformatics Collaboration Europe's best companies using bioinformatics to tackle cancer will take part in a huge collaboration aimed at developing personalized cancer… December 1, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jul 2016‘Winner Antibody’ holds promise as universal Influenza A Vaccine MedImmune and Humabs have reasons to be happy. Their candidate for an Influenza A vaccine has made it into well-known… July 21, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 24 Mar 2016Novel Antibody for Influenza gets FDA Fast-Track Approval Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track… March 24, 2016 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 18 Dec 201564 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives Ablynx, the Alpaca Nanobody Biotech from Belgium, has completed target enrollment of the first-in-infant Phase I/IIa study with its anti-Respiratory… December 18, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 26 Nov 2015The UK-Israeli €378M Small-Molecule Offensive Against Migraines The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up on novel drug therapies targeting… November 26, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 20 Nov 2015Get to Know the Top 50 Women in the UK’s Biotech Scene The Movers & Shakers Report 2015 lists 50 of the Top female Bio-Entrepreneurs... here's a select few I found particularly… November 20, 2015 - 5 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2015How Big can be Small in Biotech – #BIO-Europe 2015 Keynote As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and… November 2, 2015 - 5 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2015For when it actually is Lupus: New Autoimmune Crisis Drug reaches Human Trials ArGEN-X from Ghent (BE) and Breda (NL) has initiated its phase I human trials for Auto-immune diseases such as systemic… October 22, 2015 - 4 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2015AstraZeneca’s Oncology Expansion Continues: MedImmune grabs Inovio’s Cancer Vaccine The massive expansion of AstraZeneca's pipeline continues, as its biological subsidiary, MedImmune buys Inovio Pharmaceuticals' clinical-stage cancer vaccine that targets… August 11, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jul 2015Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private investors to push forward its T… July 16, 2015 - 3 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jul 2015Lilly Cooperates with Immunocore to Fight Skin Cancer Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based drug, IMCgp100 is tested in… July 3, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jun 2015Novartis Uses Antibodies from Cured Patients to Fight Viruses Novartis just paid the bill to Humabs to use its out-licensed drug candidate in a Phase II clinical trial. This monoclonal… June 16, 2015 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2014New Collaboration for New Cancer Therapies Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered into a collaboration to establish… September 30, 2014 - 2 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email